The World Market for Vaccines, Antisera, and Other Blood Fractions: A 2021 Global Trade Perspective

September 2020 •
297 pages •
Report ID: 3033912 •
Format: PDF

Summary
Table of contents

This series was created for international firms who rely on foreign export markets for a substantial portion of their business or who might be threatened by foreign trade competition. The estimates given in this report were created using a methodology developed by and under the direct supervision of Professor Philip M. Parker, the Chair Professor of Management Science at INSEAD. The methodology relies on historical figures of economic growth and trade flows of some 150 countries for over 2,500 industrial or product categories. The figures should be seen as market estimates, as opposed to historical records, as these are projected for the current year of trade.

On the demand side, exporters and strategic planners approaching the world market face a number of questions. Which countries are supplying vaccines, antisera, and other blood fractions? What is the dollar value of these imports? How much do the imports of vaccines, antisera, and other blood fractions vary from one country to another? Do exporters serving the world market have similar market shares across the importing countries? Which countries supply the most exports of vaccines, antisera, and other blood fractions? Which countries are buying their exports? What is the value of these exports and which countries are the largest buyers?

"Vaccines, antisera, and other blood fractions" as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defines "vaccines, antisera, and other blood fractions" is 54163.

Ahmad helps you find the right report:

+1 718 618 4302
Contact by email

FAQ

Testimonials

The market research advisor answered my questions quickly and professionally. ReportBuyer's team did their best to ensure that I felt comfortable before making the investment to purchase the report.

Cristian Nunez

Director of Corporate Development Chugach Alaska Corporation

My overall experience with ReportBuyer today has been very positive, and I must thank you for your patience (...). Also, the sample you sent me and the explanations provided were very helpful.

D. Lescuyer

Executive Vice President Oral Business at Skyepharma

The research specialist was very helpful, and proposed the best content for my needs. ReportBuyer also offered a great follow-up, thanks for everything !

P. Thompson

EMEA Managing Director

We were satisfied with the support that ReportBuyer's team provided. Thanks to their recommendations, the report we purchased provided exactly what we want.

Y. Wang

Business Analyst

We didn't have time to do the research internally, and thanks to ReportBuyer's team we were able to find the appropriate data.

S. Chen

Research Coordinator

I was impressed by the customer service: it was fast, responsive, and 100% professional !

D. Krivan

Market Research Analyst

The research specialist provided prompt and helpful service. He also followed up to ensure I had all the information to deliver my business development plan.

C. Adams

Senior Business Development Manager